Clinical Trial Update: Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two different sequences of bevacizumab and verteporfin for neovascular age-related macular degeneration; the trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Retinal Consultants Medical Group | Conditions: Choroidal Neovascularization, Macular Degeneration | Phase 2 | Status: COMPLETED